Prostatis Group’s GitLab GTLB Stock Holding History

Prostatis Group’s Portfolio GTLB Stock Details GTLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,051	Closed	-$273K	–	173
2025 Q3	$273K	Buy	6,051 +368	+6%	+$16.8K	0.07%	142
2025 Q2	$256K	Buy	+5,683	New	+$260K	0.07%	131

Other funds holding GTLB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

HCM

HMI Capital Management San Francisco, California $712M AUM 26.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Prostatis Group's GTLB Position: Q4 2025 in Review

Prostatis Group sold out of GitLab (GTLB) in Q4 2025, closing a stake of 6,051 shares — an estimated $273K sold.

Prostatis Group first reported a position in GTLB in Q2 2025 and held it in 2 quarters. The position peaked at $273K in Q3 2025. 437 funds tracked by Wall St. Rank hold GTLB as of Q4 2025.

Prostatis Group reported no remaining GitLab position as of Q4 2025 after selling out during the quarter.
Prostatis Group sold 6,051 GitLab shares in Q4 2025, an estimated $273K.
Prostatis Group first reported a position in GitLab in Q2 2025 and held it in 2 quarters.
Prostatis Group's GitLab position peaked at $273K in Q3 2025.
437 funds tracked by Wall St. Rank held GitLab as of Q4 2025.

Based on Prostatis Group's 13F filing for Q4 2025, filed 17 Feb 2026.